Ophthalmology Times: January 2021

Investigators focus on biophysical method to study protein-protein interactions .

While current treatments are good, the best is yet to come.

Drops can simplify dosing, improving adherence and ocular surface health

Consider ideas about outflow pathways, neuroprotection.

Investigators examine long-term effects of therapeutics in infants.

Peptides offering ophthalmologists a potential treatment option for keratitis.

Once-daily corticosteroid treats pain, inflammation after surgery.

Noninvasive option reduces IOP in patients with glaucoma.

Community involvement, research continue to boost treatment in pediatric population.

Emerging technology may facilitate individualized care, disease management.

Organization shines spotlight on frontline heroes during ongoing COVID-19 battle.

For ophthalmologists, practice makes perfect in becoming ambidextrous.

Physician pioneers technique offering higher perspective in surgery, outcomes.

Sometimes, physicians may find that falling behind is the right thing to do.

Check out the latest cartoon!

Minimally invasive conjunctival surgery option is an efficient procedure.

Study supports preoperative ocular surface optimization with artificial tears.

All syringes used for intravitreal injections have pros and cons. Some recently marketed and forthcoming products are coming closer to meeting “ideal” criteria.